Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity

Authors

Christian Perez-Shibayama, Kantonsspital St. Gallen
Cristina Gil-Cruz, Kantonsspital St. Gallen
Monika Nussbacher, Kantonsspital St. Gallen
Eva Allgauer, Kantonsspital St. Gallen
Luisa Cervantes-Barragan, Washington University School of Medicine in St. Louis
Roland Zust, Kantonsspital St. Gallen
Burkhard Ludewig, Kantonsspital St. Gallen

Journal

PLoS One

Publication Date

2013

Volume

8

Issue

11

Inclusive Pages

e81442

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0081442

Rights and Permissions

Perez-Shibayama C, Gil-Cruz C, Nussbacher M, Allgäuer E, Cervantes-Barragan L, et al. (2013) Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity. PLoS ONE 8(11): e81442. doi: 10.1371/journal.pone.0081442

Recommended Citation

Perez-Shibayama, Christian; Gil-Cruz, Cristina; Nussbacher, Monika; Allgauer, Eva; Cervantes-Barragan, Luisa; Zust, Roland; and Ludewig, Burkhard, "Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity." PLoS One. 8, 11. e81442. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/2580